Results 101 to 110 of about 32,749 (181)

Human Papillomavirus Type 16 E6 Seroprevalence among Men Living with HIV without HPV-Driven Malignancies

open access: yesCancer Prevention Research
Abstract Individuals living with human immunodeficiency virus (HIV) are at a higher risk for developing human papillomavirus–driven oropharyngeal squamous cell carcinoma (HPV + OPSCC). There are no methods for early detection; however, HPV16 E6 antibodies have been identified as a promising early marker.
Ashley J. Duff   +14 more
openaire   +3 more sources

RIPOR2 Expression Decreased by HPV-16 E6 and E7 Oncoproteins: An Opportunity in the Search for Prognostic Biomarkers in Cervical Cancer. [PDF]

open access: yesCells, 2022
Olmedo-Nieva L   +9 more
europepmc   +1 more source

Association between the p53 arginine/arginine homozygous genotype at codon 72 and human papillomavirus E6/E7 mRNA expression

open access: yesBrazilian Journal of Infectious Diseases, 2017
Objective: To evaluate the association between p53 polymorphisms and human papillomavirus (HPV) E6/E7 mRNA expression. Methods: We analyzed 175 cervical samples from women aged 16–69 years old who were tested for HPV E6/E7 mRNA expression (NucliSENS ...
Ana Carolina Silva Chuery   +3 more
doaj   +1 more source

Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran [PDF]

open access: yes, 2006
Introduction: HPV infection has a prime etiologic role in development and progression of cervical cancer, one of the most frequent forms of cancer among women in developing countries.
Dastan, J.   +9 more
core  

Fowlpox virus recombinants expressing HPV-16 E6 and E7 oncogenes for the therapy of cervical carcinoma elicit humoral and cell-mediated responses in rabbits

open access: yesJournal of Translational Medicine, 2010
Background Around half million new cases of cervical cancer arise each year, making the development of an effective therapeutic vaccine against HPV a high priority.
Pacchioni Sole   +4 more
doaj   +1 more source

Effect of HPV 16 E6 Oncoprotein Variants on the Alterations of the Proteome of C33A Cells. [PDF]

open access: yesCancer Genomics Proteomics, 2021
Garibay-Cerdenares OL   +9 more
europepmc   +1 more source

Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions. [PDF]

open access: yesJ Immunother Cancer, 2022
Speetjens FM   +18 more
europepmc   +1 more source

Molecular epidemiology of high-risk types of Human Papillomaviruses (16, 18) in pap-smear, the North East of Iran [PDF]

open access: yes, 2011
Background: Cervical Cancer is one of the most important and commonly diagnosed types of cancer in females. There are different causes of cervical cancer, amongst which recurrent and persistent infection with HPV types 16 and 18 are the most renowned ...
Bakhshandeh Nosrat, S.   +2 more
core   +1 more source

HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial. [PDF]

open access: yesJ Immunother Cancer, 2021
Bakker NAM   +15 more
europepmc   +1 more source

Production of recombinant HPV11/16 E6/E7-MBP-His6 fusion proteins and their potential to induce cytokine secretion by immune cells in peripheral blood

open access: yesVirology Journal
Human papillomavirus (HPV) infection poses a significant threat to public health worldwide. Targeting the function of HPV E6 and E7 proteins and activating the host immune response against these proteins represent promising therapeutic strategies for ...
Mei-nian Xu   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy